Dr. Raymond De Vré, senior VP and head of Business Operations and Strategy, Biologics at Dr. Reddy’s in Switzerland, discusses scaling up the Indian-headquartered company’s biosimilars business globally and the importance of selecting Switzerland as the location for regional headquarters.
The main challenge in the mature markets is the stringency of the regulatory frameworks: the sheer amount of clinical, non-clinical and analytical evidence that is required is extremely demanding and can be very expensive
